Tag: prostate cancer

GlycoNet start-up GlyCa Biosciences Inc. and Huron Innovation Inc. partner to improve prostate cancer detection

GlycoNet start-up GlyCa Biosciences Inc. and Huron Innovation Inc. partner to improve prostate cancer detection

This partnership will launch the clinical trial of a new blood test to perfect early detection and diagnosis of clinically significant prostate cancer.

GlycoNet scientist discusses novel biomarkers that aim to revolutionize care for prostate cancer patients

GlycoNet scientist discusses novel biomarkers that aim to revolutionize care for prostate cancer patients

By Anushka Jayasuriya & Chardelle Prevatt – June 23, 2017 Prostate cancer, the most commonly diagnosed cancer in Canadian men, is currently screened using the prostate-specific antigen (PSA) serum test. However, in 30% of cases, PSA is elevated for reasons other than prostate cancer; as a result, prostate cancer is also the most over-treated cancer. […]

en_USEnglish
Scroll to Top